1. Home
  2. HUDI vs GDTC Comparison

HUDI vs GDTC Comparison

Compare HUDI & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huadi International Group Co. Ltd.

HUDI

Huadi International Group Co. Ltd.

N/A

Current Price

$1.27

Market Cap

18.1M

Sector

Industrials

ML Signal

N/A

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

N/A

Current Price

$1.06

Market Cap

15.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HUDI
GDTC
Founded
1998
2018
Country
China
Singapore
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.1M
15.5M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
HUDI
GDTC
Price
$1.27
$1.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
46.2K
35.9K
Earning Date
02-02-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$66,566,370.00
$573,193.00
Revenue This Year
N/A
$5.37
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
63.03
52 Week Low
$1.06
$0.86
52 Week High
$5.46
$3.68

Technical Indicators

Market Signals
Indicator
HUDI
GDTC
Relative Strength Index (RSI) 56.69 30.91
Support Level $1.24 $0.86
Resistance Level $1.35 $1.13
Average True Range (ATR) 0.08 0.12
MACD 0.01 -0.01
Stochastic Oscillator 80.49 33.00

Price Performance

Historical Comparison
HUDI
GDTC

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: